aluates Reports

$ 0.0

Automative

Global Companion Diagnostics for Oncology Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-5I10208

Global Companion Diagnostics for Oncology Market Insights Forecast to 2028

BUY CHAPTERS

Global Companion Diagnostics for Oncology Market Research Report 2025

Code: QYRE-Auto-5I10208

Report

July 2025

Pages:71

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Agilent Technologies

Illumina Inc

Roche

bioMérieux

Foundation Medicine

Archerdx

Qiagen NV

Thermo Fisher Scientific

Amoy Diagnostics

Abbott

Companion Diagnostics for Oncology Market Size

The global market for Companion Diagnostics for Oncology was valued at US$ 4977 million in the year 2024 and is projected to reach a revised size of US$ 10100 million by 2031, growing at a CAGR of 10.8% during the forecast period.

Companion Diagnostics for Oncology Market

Companion diagnostic (CDx) is a diagnostic testing kit majorly used by pharmaceutical companies for the development of personalized medicine. CDx tests provide information about the effective use of a corresponding therapeutic product by analyzing the genetic material. With the rise in cancer prevalence, coupled with increasing strategic initiatives, there has been a huge demand for companion diagnostics in the oncology area.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Companion Diagnostics for Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Diagnostics for Oncology.

The Companion Diagnostics for Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Companion Diagnostics for Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Companion Diagnostics for Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Companion Diagnostics for Oncology Market Report

Report Metric	Details
Report Name	Companion Diagnostics for Oncology Market
Accounted market size in year	US$ 4977 million
Forecasted market size in 2031	US$ 10100 million
CAGR	10.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Polymerase Chain Reaction (PCR) Next-Generation Sequencing (NGS)
Segment by Application	Pharmaceutical and Biopharmaceutical Companies Contract Research Organizations Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Agilent Technologies, Illumina, Roche, BioMérieux, Foundation Medicine, ArcherDX, Qiagen, Thermo Fisher Scientific, Amoy Diagnostics, Abbott
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Companion Diagnostics for Oncology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Companion Diagnostics for Oncology Market growing?

Ans: The Companion Diagnostics for Oncology Market witnessing a CAGR of 10.8% during the forecast period 2025-2031.

What is the Companion Diagnostics for Oncology Market size in 2031?

Ans: The Companion Diagnostics for Oncology Market size in 2031 will be US$ 10100 million.

Who are the main players in the Companion Diagnostics for Oncology Market report?

Ans: The main players in the Companion Diagnostics for Oncology Market are Agilent Technologies, Illumina, Roche, BioMérieux, Foundation Medicine, ArcherDX, Qiagen, Thermo Fisher Scientific, Amoy Diagnostics, Abbott

What are the Application segmentation covered in the Companion Diagnostics for Oncology Market report?

Ans: The Applications covered in the Companion Diagnostics for Oncology Market report are Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Laboratories, Others

What are the Type segmentation covered in the Companion Diagnostics for Oncology Market report?

Ans: The Types covered in the Companion Diagnostics for Oncology Market report are Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS)

Recommended Reports

Oncology Diagnostics

Cancer Therapeutics

Companion and Molecular Diagnostics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Companion Diagnostics for Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Polymerase Chain Reaction (PCR)

1.2.3 Next-Generation Sequencing (NGS)

1.3 Market by Application

1.3.1 Global Companion Diagnostics for Oncology Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical and Biopharmaceutical Companies

1.3.3 Contract Research Organizations

1.3.4 Laboratories

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Companion Diagnostics for Oncology Market Perspective (2020-2031)

2.2 Global Companion Diagnostics for Oncology Growth Trends by Region

2.2.1 Global Companion Diagnostics for Oncology Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Companion Diagnostics for Oncology Historic Market Size by Region (2020-2025)

2.2.3 Companion Diagnostics for Oncology Forecasted Market Size by Region (2026-2031)

2.3 Companion Diagnostics for Oncology Market Dynamics

2.3.1 Companion Diagnostics for Oncology Industry Trends

2.3.2 Companion Diagnostics for Oncology Market Drivers

2.3.3 Companion Diagnostics for Oncology Market Challenges

2.3.4 Companion Diagnostics for Oncology Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Companion Diagnostics for Oncology Players by Revenue

3.1.1 Global Top Companion Diagnostics for Oncology Players by Revenue (2020-2025)

3.1.2 Global Companion Diagnostics for Oncology Revenue Market Share by Players (2020-2025)

3.2 Global Companion Diagnostics for Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Companion Diagnostics for Oncology Revenue

3.4 Global Companion Diagnostics for Oncology Market Concentration Ratio

3.4.1 Global Companion Diagnostics for Oncology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostics for Oncology Revenue in 2024

3.5 Global Key Players of Companion Diagnostics for Oncology Head office and Area Served

3.6 Global Key Players of Companion Diagnostics for Oncology, Product and Application

3.7 Global Key Players of Companion Diagnostics for Oncology, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Companion Diagnostics for Oncology Breakdown Data by Type

4.1 Global Companion Diagnostics for Oncology Historic Market Size by Type (2020-2025)

4.2 Global Companion Diagnostics for Oncology Forecasted Market Size by Type (2026-2031)

5 Companion Diagnostics for Oncology Breakdown Data by Application

5.1 Global Companion Diagnostics for Oncology Historic Market Size by Application (2020-2025)

5.2 Global Companion Diagnostics for Oncology Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Companion Diagnostics for Oncology Market Size (2020-2031)

6.2 North America Companion Diagnostics for Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Companion Diagnostics for Oncology Market Size by Country (2020-2025)

6.4 North America Companion Diagnostics for Oncology Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Companion Diagnostics for Oncology Market Size (2020-2031)

7.2 Europe Companion Diagnostics for Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Companion Diagnostics for Oncology Market Size by Country (2020-2025)

7.4 Europe Companion Diagnostics for Oncology Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Companion Diagnostics for Oncology Market Size (2020-2031)

8.2 Asia-Pacific Companion Diagnostics for Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Companion Diagnostics for Oncology Market Size by Region (2020-2025)

8.4 Asia-Pacific Companion Diagnostics for Oncology Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Companion Diagnostics for Oncology Market Size (2020-2031)

9.2 Latin America Companion Diagnostics for Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Companion Diagnostics for Oncology Market Size by Country (2020-2025)

9.4 Latin America Companion Diagnostics for Oncology Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Companion Diagnostics for Oncology Market Size (2020-2031)

10.2 Middle East & Africa Companion Diagnostics for Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Companion Diagnostics for Oncology Market Size by Country (2020-2025)

10.4 Middle East & Africa Companion Diagnostics for Oncology Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Agilent Technologies

11.1.1 Agilent Technologies Company Details

11.1.2 Agilent Technologies Business Overview

11.1.3 Agilent Technologies Companion Diagnostics for Oncology Introduction

11.1.4 Agilent Technologies Revenue in Companion Diagnostics for Oncology Business (2020-2025)

11.1.5 Agilent Technologies Recent Development

11.2 Illumina

11.2.1 Illumina Company Details

11.2.2 Illumina Business Overview

11.2.3 Illumina Companion Diagnostics for Oncology Introduction

11.2.4 Illumina Revenue in Companion Diagnostics for Oncology Business (2020-2025)

11.2.5 Illumina Recent Development

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Companion Diagnostics for Oncology Introduction

11.3.4 Roche Revenue in Companion Diagnostics for Oncology Business (2020-2025)

11.3.5 Roche Recent Development

11.4 BioMérieux

11.4.1 BioMérieux Company Details

11.4.2 BioMérieux Business Overview

11.4.3 BioMérieux Companion Diagnostics for Oncology Introduction

11.4.4 BioMérieux Revenue in Companion Diagnostics for Oncology Business (2020-2025)

11.4.5 BioMérieux Recent Development

11.5 Foundation Medicine

11.5.1 Foundation Medicine Company Details

11.5.2 Foundation Medicine Business Overview

11.5.3 Foundation Medicine Companion Diagnostics for Oncology Introduction

11.5.4 Foundation Medicine Revenue in Companion Diagnostics for Oncology Business (2020-2025)

11.5.5 Foundation Medicine Recent Development

11.6 ArcherDX

11.6.1 ArcherDX Company Details

11.6.2 ArcherDX Business Overview

11.6.3 ArcherDX Companion Diagnostics for Oncology Introduction

11.6.4 ArcherDX Revenue in Companion Diagnostics for Oncology Business (2020-2025)

11.6.5 ArcherDX Recent Development

11.7 Qiagen

11.7.1 Qiagen Company Details

11.7.2 Qiagen Business Overview

11.7.3 Qiagen Companion Diagnostics for Oncology Introduction

11.7.4 Qiagen Revenue in Companion Diagnostics for Oncology Business (2020-2025)

11.7.5 Qiagen Recent Development

11.8 Thermo Fisher Scientific

11.8.1 Thermo Fisher Scientific Company Details

11.8.2 Thermo Fisher Scientific Business Overview

11.8.3 Thermo Fisher Scientific Companion Diagnostics for Oncology Introduction

11.8.4 Thermo Fisher Scientific Revenue in Companion Diagnostics for Oncology Business (2020-2025)

11.8.5 Thermo Fisher Scientific Recent Development

11.9 Amoy Diagnostics

11.9.1 Amoy Diagnostics Company Details

11.9.2 Amoy Diagnostics Business Overview

11.9.3 Amoy Diagnostics Companion Diagnostics for Oncology Introduction

11.9.4 Amoy Diagnostics Revenue in Companion Diagnostics for Oncology Business (2020-2025)

11.9.5 Amoy Diagnostics Recent Development

11.10 Abbott

11.10.1 Abbott Company Details

11.10.2 Abbott Business Overview

11.10.3 Abbott Companion Diagnostics for Oncology Introduction

11.10.4 Abbott Revenue in Companion Diagnostics for Oncology Business (2020-2025)

11.10.5 Abbott Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Agilent Technologies

Illumina Inc

Roche

bioMérieux

Foundation Medicine

Archerdx

Qiagen NV

Thermo Fisher Scientific

Amoy Diagnostics

Abbott

List of Tables

Table 1. Global Companion Diagnostics for Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Polymerase Chain Reaction (PCR)

Table 3. Key Players of Next-Generation Sequencing (NGS)

Table 4. Global Companion Diagnostics for Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Companion Diagnostics for Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Companion Diagnostics for Oncology Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Companion Diagnostics for Oncology Market Share by Region (2020-2025)

Table 8. Global Companion Diagnostics for Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Companion Diagnostics for Oncology Market Share by Region (2026-2031)

Table 10. Companion Diagnostics for Oncology Market Trends

Table 11. Companion Diagnostics for Oncology Market Drivers

Table 12. Companion Diagnostics for Oncology Market Challenges

Table 13. Companion Diagnostics for Oncology Market Restraints

Table 14. Global Companion Diagnostics for Oncology Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Companion Diagnostics for Oncology Market Share by Players (2020-2025)

Table 16. Global Top Companion Diagnostics for Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics for Oncology as of 2024)

Table 17. Ranking of Global Top Companion Diagnostics for Oncology Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Companion Diagnostics for Oncology Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Companion Diagnostics for Oncology, Headquarters and Area Served

Table 20. Global Key Players of Companion Diagnostics for Oncology, Product and Application

Table 21. Global Key Players of Companion Diagnostics for Oncology, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Companion Diagnostics for Oncology Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Companion Diagnostics for Oncology Revenue Market Share by Type (2020-2025)

Table 25. Global Companion Diagnostics for Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Companion Diagnostics for Oncology Revenue Market Share by Type (2026-2031)

Table 27. Global Companion Diagnostics for Oncology Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Companion Diagnostics for Oncology Revenue Market Share by Application (2020-2025)

Table 29. Global Companion Diagnostics for Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Companion Diagnostics for Oncology Revenue Market Share by Application (2026-2031)

Table 31. North America Companion Diagnostics for Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Companion Diagnostics for Oncology Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Companion Diagnostics for Oncology Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Companion Diagnostics for Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Companion Diagnostics for Oncology Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Companion Diagnostics for Oncology Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Companion Diagnostics for Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Companion Diagnostics for Oncology Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Companion Diagnostics for Oncology Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Companion Diagnostics for Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Companion Diagnostics for Oncology Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Companion Diagnostics for Oncology Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Companion Diagnostics for Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Companion Diagnostics for Oncology Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Companion Diagnostics for Oncology Market Size by Country (2026-2031) & (US$ Million)

Table 46. Agilent Technologies Company Details

Table 47. Agilent Technologies Business Overview

Table 48. Agilent Technologies Companion Diagnostics for Oncology Product

Table 49. Agilent Technologies Revenue in Companion Diagnostics for Oncology Business (2020-2025) & (US$ Million)

Table 50. Agilent Technologies Recent Development

Table 51. Illumina Company Details

Table 52. Illumina Business Overview

Table 53. Illumina Companion Diagnostics for Oncology Product

Table 54. Illumina Revenue in Companion Diagnostics for Oncology Business (2020-2025) & (US$ Million)

Table 55. Illumina Recent Development

Table 56. Roche Company Details

Table 57. Roche Business Overview

Table 58. Roche Companion Diagnostics for Oncology Product

Table 59. Roche Revenue in Companion Diagnostics for Oncology Business (2020-2025) & (US$ Million)

Table 60. Roche Recent Development

Table 61. BioMérieux Company Details

Table 62. BioMérieux Business Overview

Table 63. BioMérieux Companion Diagnostics for Oncology Product

Table 64. BioMérieux Revenue in Companion Diagnostics for Oncology Business (2020-2025) & (US$ Million)

Table 65. BioMérieux Recent Development

Table 66. Foundation Medicine Company Details

Table 67. Foundation Medicine Business Overview

Table 68. Foundation Medicine Companion Diagnostics for Oncology Product

Table 69. Foundation Medicine Revenue in Companion Diagnostics for Oncology Business (2020-2025) & (US$ Million)

Table 70. Foundation Medicine Recent Development

Table 71. ArcherDX Company Details

Table 72. ArcherDX Business Overview

Table 73. ArcherDX Companion Diagnostics for Oncology Product

Table 74. ArcherDX Revenue in Companion Diagnostics for Oncology Business (2020-2025) & (US$ Million)

Table 75. ArcherDX Recent Development

Table 76. Qiagen Company Details

Table 77. Qiagen Business Overview

Table 78. Qiagen Companion Diagnostics for Oncology Product

Table 79. Qiagen Revenue in Companion Diagnostics for Oncology Business (2020-2025) & (US$ Million)

Table 80. Qiagen Recent Development

Table 81. Thermo Fisher Scientific Company Details

Table 82. Thermo Fisher Scientific Business Overview

Table 83. Thermo Fisher Scientific Companion Diagnostics for Oncology Product

Table 84. Thermo Fisher Scientific Revenue in Companion Diagnostics for Oncology Business (2020-2025) & (US$ Million)

Table 85. Thermo Fisher Scientific Recent Development

Table 86. Amoy Diagnostics Company Details

Table 87. Amoy Diagnostics Business Overview

Table 88. Amoy Diagnostics Companion Diagnostics for Oncology Product

Table 89. Amoy Diagnostics Revenue in Companion Diagnostics for Oncology Business (2020-2025) & (US$ Million)

Table 90. Amoy Diagnostics Recent Development

Table 91. Abbott Company Details

Table 92. Abbott Business Overview

Table 93. Abbott Companion Diagnostics for Oncology Product

Table 94. Abbott Revenue in Companion Diagnostics for Oncology Business (2020-2025) & (US$ Million)

Table 95. Abbott Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Companion Diagnostics for Oncology Picture

Figure 2. Global Companion Diagnostics for Oncology Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Companion Diagnostics for Oncology Market Share by Type: 2024 VS 2031

Figure 4. Polymerase Chain Reaction (PCR) Features

Figure 5. Next-Generation Sequencing (NGS) Features

Figure 6. Global Companion Diagnostics for Oncology Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Companion Diagnostics for Oncology Market Share by Application: 2024 VS 2031

Figure 8. Pharmaceutical and Biopharmaceutical Companies Case Studies

Figure 9. Contract Research Organizations Case Studies

Figure 10. Laboratories Case Studies

Figure 11. Others Case Studies

Figure 12. Companion Diagnostics for Oncology Report Years Considered

Figure 13. Global Companion Diagnostics for Oncology Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Companion Diagnostics for Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Companion Diagnostics for Oncology Market Share by Region: 2024 VS 2031

Figure 16. Global Companion Diagnostics for Oncology Market Share by Players in 2024

Figure 17. Global Top Companion Diagnostics for Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics for Oncology as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Companion Diagnostics for Oncology Revenue in 2024

Figure 19. North America Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Companion Diagnostics for Oncology Market Share by Country (2020-2031)

Figure 21. United States Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Companion Diagnostics for Oncology Market Share by Country (2020-2031)

Figure 25. Germany Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Companion Diagnostics for Oncology Market Share by Region (2020-2031)

Figure 33. China Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Companion Diagnostics for Oncology Market Share by Country (2020-2031)

Figure 41. Mexico Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Companion Diagnostics for Oncology Market Share by Country (2020-2031)

Figure 45. Turkey Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Companion Diagnostics for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Agilent Technologies Revenue Growth Rate in Companion Diagnostics for Oncology Business (2020-2025)

Figure 49. Illumina Revenue Growth Rate in Companion Diagnostics for Oncology Business (2020-2025)

Figure 50. Roche Revenue Growth Rate in Companion Diagnostics for Oncology Business (2020-2025)

Figure 51. BioMérieux Revenue Growth Rate in Companion Diagnostics for Oncology Business (2020-2025)

Figure 52. Foundation Medicine Revenue Growth Rate in Companion Diagnostics for Oncology Business (2020-2025)

Figure 53. ArcherDX Revenue Growth Rate in Companion Diagnostics for Oncology Business (2020-2025)

Figure 54. Qiagen Revenue Growth Rate in Companion Diagnostics for Oncology Business (2020-2025)

Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostics for Oncology Business (2020-2025)

Figure 56. Amoy Diagnostics Revenue Growth Rate in Companion Diagnostics for Oncology Business (2020-2025)

Figure 57. Abbott Revenue Growth Rate in Companion Diagnostics for Oncology Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Companion Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Companion Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Digital Companion Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncology Companion Diagnostic Market Research Report 2024

Global Companion Diagnostics CDx Development Services Market Research Report 2024

Companion Diagnostic Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Companion Diagnostics Devices Market Research Report 2025

Companion Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmacogenomics Technology Theranostics Companion Diagnostics CDx Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Companion Animal Diagnostics Market Research Report 2024

Companion Animal Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Breast Cancer Testing Market Insights Forecast to 2030

Precision Cancer Diagnostic Tests Market

Global Hematology Oncology Diagnostics Market Research Report 2024

Global Cancer Test Kit Market Insights Forecast to 2030

Global Precision Cancer Tests Market Research Report 2024

Global Molecular Diagnostics Cancer Market Insights Forecast to 2030

Global Computer Aided Diagnostics CADx Market Research Report 2024

Global Molecular Oncology Market Research Report 2024

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16G6108

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-27Q5892

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14K19926

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15N17310

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions